Recent Funding
Investors
Oncology Ventures

Oncology Ventures portfolio

Oncology Ventures has 3 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Website: oncology.ventures.

Type: Venture capital.

Portfolio on Recent Funding: 3.

Deals, last 12 months: 2.

Capital in their rounds: $33.6M.

Latest deal: Nexcure · Mar 5, 2026.

About this page

It is a venture capital firm based in New York, US, founded in 2018. Its most recent investment on record is Nexcure's $19M Series A round in March 2026, alongside Cencora Ventures and RA Capital Management. By category, its portfolio leans toward Health and bio (3). It has co-invested with Cencora Ventures, z21 Ventures and RA Capital Management, most often Cencora Ventures (2 rounds).

About Oncology Ventures

Firm type: Venture capital.

Headquarters: New York, US.

Founded: 2018.

Stages: Seed, Series A, Series B.

Sectors: AI & Machine Learning, Biotech, Data & Infrastructure, Digital Health, Healthtech, Medical Devices.

Portfolio companies: 26.

Exits: 0.

Rounds led: 0.

Funds raised

Fund	Fund #	Size	Announced
OOncology Ventures	II	$62M	Apr 22, 2026 Business Wire
OOncology Ventures NYC	Ifirst fund	$30M	Aug 26, 2024 techcrunch.com

What Oncology Ventures invests in

Health and bio · 3 · 100%

Oncology Ventures recent investments

Company	Round	Date	Alongside
NNexcure	Series A · $19M	Mar 5, 2026	Cencora Ventures, RA Capital Management (lead)
RRisa Labs	Series A · $11.1M	Jan 14, 2026	Cencora Ventures (lead), Ventureforgood, z21 Ventures +1
RRisa Labs	Seed · $3.5M	Apr 18, 2025	ODD BIRD VC, General Catalyst, Binny Bansal (lead) +1

How Oncology Ventures invests

Stage	Deals	Capital in rounds
Series A	2 67%	$30.1M
Seed	1 33%	$3.5M

Year	Deals	Capital in rounds
2025	1 33%	$3.5M
2026	2 67%	$30.1M

Oncology Ventures portfolio companies

NNexcure$19MSeries A · Mar 2026
RRisa Labs$11.1MSeries A · Jan 2026
IIgniteDatabacker

Company	Round with Oncology Ventures	Total raised	Latest raise
NNexcure Health and bio	Mar 5, 2026 Series A · $19M	$19M	Mar 5, 2026 Series A
RRisa Labs Health and bio	Jan 14, 2026 Series A · $11.1M	$14.6M	Jan 14, 2026 Series A
IIgniteData Health and bio	backer	$11M	Nov 5, 2025 Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Venture funds Oncology Ventures raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

Share is of the 3 rounds on Recent Funding that name Oncology Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Oncology Ventures, which is a subset of its real portfolio. API: /api/v1/investors/oncology-ventures (get a free API key). More: the most active VC firms and new venture capital funds.